In silico molecular engineering for a targeted replacement in a tumor-homing peptide

David Zanuy, Alejandra Flores-Ortega, Ana I. Jiménez, M. Isabel Calaza, Carlos Cativiela, Ruth Nussinov, Erkki Ruoslahti, Carlos Alemán

Research output: Contribution to journalArticlepeer-review

Abstract

A new amino acid has been designed as a replacement for arginine (Arg, R) to protect the tumor-homing pentapeptide CREKA (Cys-Arg-Glu-Lys-Ala) from proteases. This amino acid, denoted (Pro)hArg, is characterized by a proline skeleton bearing a specifically oriented guanidinium side chain. This residue combines the ability of Pro to induce turn-like conformations with the Arg side-chain functionality. The conformational profile of the CREKA analogue incorporating this Arg substitute has been investigated by a combination of simulated annealing and molecular dynamics. Comparison of the results with those previously obtained for the natural CREKA shows that (Pro)hArg significantly reduces the conformational flexibility of the peptide. Although some changes are observed in the backbone ⋯ backbone and side-chain ⋯ side-chain interactions, the modified peptide exhibits a strong tendency to accommodate turn conformations centered at the (Pro)hArg residue and the overall shape of the molecule in the lowest energy conformations characterized for the natural and the modified peptides exhibit a high degree of similarity. In particular, the turn orients the backbone such that the Arg, Glu, and Lys side chains face the same side of the molecule, which is considered important for bioactivity. These results suggest that replacement of Arg by (Pro)hArg in CREKA may be useful in providing resistance against proteolytic enzymes while retaining conformational features which are essential for tumorhoming activity.

Original languageEnglish
Pages (from-to)7879-7889
Number of pages11
JournalJournal of Physical Chemistry B
Volume113
Issue number22
DOIs
StatePublished - 4 Jun 2009

Fingerprint

Dive into the research topics of 'In silico molecular engineering for a targeted replacement in a tumor-homing peptide'. Together they form a unique fingerprint.

Cite this